Majid, Sandralyn B.

HRN: 22-35-69  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2022
CEFUROXIME 750MG (VIAL)
12/26/2022
01/02/2023
IV
750mg
Q8h
Age With Moderate Dhn
Waiting Final Action 
12/27/2022
CEFTRIAXONE 1G (VIAL)
12/27/2022
01/03/2023
IV
2g
Q24h
Age With Moderate Dhn, Uti
Waiting Final Action 
12/27/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/27/2022
01/03/2023
IV
500mg
Q8h
Age With Moderate Dhn, Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: